BIO-RAD LABORATORIES, INC. — Director's Dealing 2019

Sep 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-10

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-10	Bio-Rad B Common Stock	M	2000	—	Acquired	279321	Direct
2019-09-10	Bio-Rad B Common Stock	F	992	$322.93	Disposed	278329	Direct
2019-09-11	Bio-Rad B Common Stock	M	3200	—	Acquired	281529	Direct
2019-09-11	Bio-Rad B Common Stock	F	1587	$326.42	Disposed	279942	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-10	Restricted Stock Units	$0	M	2000	Disposed		Bio-Rad B Common Stock (2000)	Direct
2019-09-11	Restricted Stock Units	$0	M	3200	Disposed		Bio-Rad B Common Stock (3200)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Bio-Rad A Common Stock	415182	Direct
Bio-Rad B Common Stock	12771	Indirect
Bio-Rad B Common Stock	4060054	Indirect

Footnotes

F1: Shares of Class B common stock acquired on the vesting of restricted stock units.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F5: The restricted stock units vest in five equal annual installments beginning September 10, 2015.

F6: The restricted stock units vest in five equal annual installments beginning September 11, 2016.